Christopher Day
CEO @ Elevate Ventures
Indianapolis, United States
Christopher Day is a seed investor at Elevate Ventures in Indianapolis focused on Health Care and Biotechnology. Christopher Day is the CEO of Elevate Ventures. He previously worked at Sky Zone- Fishers and Schererville as a Principal. Christopher Day attended Purdue University.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 80%
Last updated:
For AI agents: llms.txt
Industries Christopher Day invests in
Stages Christopher Day invests in
Countries Christopher Day invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 2 (40%)
- Biotechnology 2 (40%)
- Pet 1 (20%)
- Dental 1 (20%)
- Medical 1 (20%)
Stage
- Seed 4 (80%)
- Convertible Note 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| GRAIN Ecosystem is a start-up that addresses global warming and accelerates decarbonization. By simplifying the process of removing carbon from the earth’s atmosphere, they can empower carbon project developers to do more.GRAIN Ecosystem is a new venture incubated at Greentown Labs, funded by Schneider Electric, and accelerated by the CleantechOpen Northeast and Microsoft Founders Hub. | $880K / Seed / Apr 08, 2025 | ||
| Amplified Sciences is a molecular diagnostics company unlike other diagnostics companies due to their ultra-sensitive molecular sensing technology with composition of matter IP exclusively licensed from Purdue University. The technology is disease state agnostic, can detect to the single molecule level, scales easily to point of care, and providesa very favorable cost structure for their platform of reagents. The first application – early detection of pancreatic cancer - is an assay that will quickly prove the investment thesis due to large unmet medical need and a favorable reimbursement path. The team has delivered a working prototype and published proof of concept data. | $2.6M / Seed / Nov 25, 2024 | ||
| PawCo Foods is the new generation of healthy and delicious pet foods made from plant-based meat. | $2M / Seed / Feb 29, 2024 | ||
| Adipo Therapeutic is a biotechnology company that develops polymer-based nanotherapeutics. Its nanotherapeutics utilizes adipocyte browning technique to convert energy-storing bad fat cells into energy-burning good fat cells to transform the treatment of obesity and type 2 diabetes, enabling patients to lose bodyweight naturally and restoringmetabolic balance for millions of people living with diabetes. | $1.9M / Convertible Note / Jan 31, 2024 | ||
| Plan Forward provides a dental membership platform designed to offer in-house membership plans to patients that do not have traditional insurance which ultimately gives more patients access to quality care and loyalty to quality providers. The company partners with dentists, group practices, and dental practice office managers to create and powertheir in-office dental membership plans.Plan Forward was established in 2018 and is headquartered in Indianapolis, Indiana. | $2M / Seed / Oct 09, 2023 |
Co-Investors
About Elevate Ventures
Elevate Ventures nurtures and develops emerging and existing high-potential businesses into high-performing, Indiana-based companies. They accomplish this by providing rigorous business analysis and robust advisory serivces that connect companies with the resources they need to succeed long-term. As a not-for-profit organization, they are able to offer unbiased, in-depth perspective and recommendations. Emerging, high-potential businesses Elevate Ventures seeks out business endeavors that identify a need in the marketplace and are well-positioned to successfully transition from research to product development to market. High-performing, Indiana-based Companies These companies grow local economies and employment throughout Indiana, in addition to attracting and retaining top-level talent for the Hoosier state. Rigorous business analysis Comprehensive due diligence is critical to determining the long-term financial viability of these companies. Robust advisory services Elevate Ventures provides more than just capital, they partner with entrepreneurs, investors and other local and state organizations to ensure the best return on investment. Resources to succeed long-term In addition to financial resources, Elevate addressees other market barriers, which may include management, business development, talent identification and retention, and specific technology development challenges. They don't just write a check and walk away - they help sustain business success and growth over time. Unbiased, in-depth perspective and recommendations With a seasoned staff and a host of proven outside partners, they provide objectivity and insights that are among the best in their profession.
Elevate Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Jonathon Fruchte
Manager
|
|||
Barbara Uggen
Chief Financial Officer
|
|||
Christina Loh
CEO Elevate Ventures - Executive Advisory & Consulting
|
|||
|
Christopher Day
CEO
|
|||
Dave Clark
Venture Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Christopher Day invest in?
Christopher Day invests primarily in Health Care, Biotechnology and Pet startups, most often at Seed and Convertible Note stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Christopher Day?
Public channels for Christopher Day include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Christopher Day last invest?
The most recent investment recorded for Christopher Day closed in Apr 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
